• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Stephen Nuckolls Outlines His Greatest Challenges and Opportunities of the Proposed MSSP Changes

Video

The proposed risk adjustment changes to the Medicare Shared Savings Program (MSSP) are welcome but moving accountable care organizations (ACOs) to risk too soon could harm the program, said Stephen Nuckolls, CEO of Coastal Carolina Quality Care.

The proposed risk adjustment changes to the Medicare Shared Savings Program (MSSP) are welcome but moving accountable care organizations (ACOs) to risk too soon could harm the program, said Stephen Nuckolls, CEO of Coastal Carolina Quality Care.

Transcript

What do you view as the greatest opportunity presented by the proposed MSSP changes? What is the greatest challenge?

I think the greatest opportunity with the new changes may be the risk adjustment; getting a positive upward adjustment really would have helped us in our first contract period. I think that is a positive for this. Also, some of the regional adjustments are also a positive for many ACOs or most ACOs.

On the negative side, making groups move to risk sooner is going to harm the program and that fewer people are going to join or you will have more dropout and the evidence has shown that when ACOs stay in longer and we have more ACOs, that the trust fund is going to save more money. I think that’s really where we need to focus on the program. Not how much savings are achieved based on the benchmark, but how much of the true savings are we achieving for the trust fund?

Related Videos
Mila Felder, MD, FACEP, emergency physician and vice president for Well-Being for All Teammates, Advocate Health
Shawn Tuma, JD, CIPP/US, cybersecurity and data privacy attorney, Spencer Fane LLP
Leslie Fish, PharmD.
Ronesh Sinha, MD
Adam Colborn, JD
Beau Raymond, MD
Judith Alberto, MHA, RPh, BCOP, director of clinical initiatives, Community Oncology Alliance
Yuqian Liu, PharmD
Related Content
© 2024 MJH Life Sciences
AJMC®
All rights reserved.